Prosus
General
Grapevine: Everstone to merge two portfolio firms; Carraro Group's India unit mulls IPO
Everstone Capital is set to merge two of its healthcare portfolio companies, Translumina Therapeutics and Everlife Holdings, in preparation for an ......
General
Grapevine: Sugar Cosmetics' VC backers eye exit; Azure Power may change hands
India-focused Malabar Investments is reportedly in discussions to acquire a stake in Mumbai-based Sugar Cosmetics through a secondary transaction worth ......
General
Grapevine: Bharti may sell life insurance unit; Captain Fresh seeks funding
Billionaire Sunil Mittal-led Bharti Group is in advanced negotiations with SBI Life and other insurers to divest its wholly owned ......
TMT
Swiggy back in decacorn club with latest valuation mark-up
Food delivery venture unicorn Swiggy, which has begun preparations for its potential public listing, has re-entered the decacorn club of ......
TMT
Heavyweight investors' bets go underwater as Byju's valuation slumps to $1 bn
Some of the world’s biggest private equity firms, asset managers, pension funds and sovereign wealth funds are now sitting on ......
TMT
Temasek, TPG, Prosus to invest more in PharmEasy as valuation slumps
Omnichannel pharmacy chain PharmEasy will raise Rs 3,500 crore through a rights issue next week, multiple people aware of the ......
TMT
Deals Digest: M&A deals hog the limelight as funding activity slows
Private equity and venture capital dealmaking slowed this week compared with the week before but there was a notable increase in merger and acquisition activities. This ......
General
Grapevine: PayU looks to list in India; Yes Bank in fray for NBFC acquisition
Prosus-backed PayU Payments Pvt. Ltd is planning to list in India sometime next year, a media report has said, citing ......
TMT
SoftBank-backed edtech firm Eruditus aims to turn profitable in FY24
Edtech company Eruditus expects to end the financial year 2023-24 on a profitable note, its founder and CEO told VCCircle, ......
Healthcare
Pharmeasy eyes $304 mn in funding from Manipal Group, existing investors
Omnichannel pharmacy chain Pharmeasy plans to raise ₹2,500 crore ($304 million) to retire the senior debt it had raised from ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News